Effects of the sodium ‐glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats

Journal of Veterinary Pharmacology and Therapeutics,Volume 41, Issue 2, Page 266-273, April 2018.
Source: Journal of Veterinary Pharmacology and Therapeutics - Category: Veterinary Research Source Type: research